Skip to main content
Lunit Inc. logo

Lunit Inc. — Investor Relations & Filings

Ticker · 328130 ISIN · KR7328130000 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 307 across all filing types
Latest filing 2025-08-07 Remuneration Information
Country KR South Korea
Listing KO 328130

About Lunit Inc.

https://www.lunit.io/

Lunit Inc. develops and provides advanced medical artificial intelligence (AI) software focused on cancer diagnostics and therapeutics. The company's core offering is a platform-based AI ecosystem designed to analyze and interpret medical data, including radiological images and pathology slides. Its solutions, such as the Lunit INSIGHT suite for mammography and chest X-ray analysis, assist healthcare professionals in the early detection of cancer, enhancing diagnostic accuracy and workflow efficiency. In precision oncology, Lunit's AI technology supports biomarker discovery and treatment response prediction by analyzing tissue pathology. The company also collaborates with biopharmaceutical partners to accelerate oncology drug development and create AI-powered companion diagnostics. Lunit's platform integrates multimodal data to provide actionable insights across the cancer care continuum, from screening to treatment.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Remuneration Information Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Amendment Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the total status of grants. This type of filing relates to capital structure and equity-based compensation, which falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the Korea Exchange/Financial Services Commission that does not fit into the other specialized categories like DIRS (which is for individual director trades) or SHA (which is for general share issuance).
2025-08-07 Korean
[기재정정]주식매수선택권부여에관한신고
Remuneration Information Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically identified as a '정정신고' (Correction Report). It details changes to previously reported stock option grants due to employee departures. This type of filing is a standard regulatory disclosure regarding capital structure and equity compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2025-08-07 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of recipients and the total number of shares granted due to employee departures. In the context of financial filings, announcements regarding stock options, capital changes, or share-related adjustments that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under 'Regulatory Filings' (RNS) as a fallback for miscellaneous corporate announcements.
2025-08-07 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is an amendment (정정신고) to a previous filing. It details changes to stock option grants, including the number of shares and the list of recipients. This type of disclosure regarding equity compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by financial authorities.
2025-08-07 Korean
[기재정정]주식매수선택권부여에관한신고
Remuneration Information Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients. This type of filing is a standard corporate disclosure regarding capital structure and equity compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2025-08-07 Korean
전환가액의조정 (제2회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in the company's stock price. This type of disclosure, which details changes to capital structure instruments like convertible bonds, falls under the 'Capital/Financing Update' category as it directly relates to the terms of the company's financing activities.
2025-08-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.